GC104 Infection Outbreak: Infection Control
An infection outbreak is the occurrence of cases of a particular infectious disease in excess of what is normally expected in a defined community or area, requiring coordinated infection control measures such as surveillance, isolation, and containment to prevent further spread.
Infection Outbreak & Infection Control
Big Idea: Infection control exists because healthcare environments concentrate vulnerable patients and dangerous microbes in close proximity. Without systematic barriers (hand hygiene, precautions, surveillance, outbreak investigation), hospitals become amplifiers of infection rather than places of healing. This lecture, delivered by Prof. KY Yuen (Chair of Microbiology, HKU), covers: (1) the history and rationale of infection control, (2) definitions of HAI/CAI, (3) modes of transmission, (4) a two-tier precaution system, (5) how to investigate an outbreak step-by-step (illustrated by the landmark QMH intestinal mucormycosis outbreak from contaminated allopurinol), and (6) sharps injury and bloodborne pathogen management. [1]
Learning Objectives:
- Define community-acquired infection (CAI), hospital-acquired infection (HAI), healthcare-associated infection (HCAI), outbreak, and pseudo-outbreak
- List the four modes of transmission (contact, droplet, aerosol/airborne, parenteral) and examples of pathogens for each
- Describe standard precautions and transmission-based precautions (contact, droplet, airborne)
- Explain the steps of outbreak investigation
- Identify key measures: hand hygiene, PPE, needle safety, vaccination, post-exposure prophylaxis
- Apply infection control principles to clinical scenarios and past-paper stems
1. History & Definitions
The recognition in 1840s by Semmelweis that microbes can be transmitted within hospitals to susceptible patients and healthcare workers was the start of infection control. [3]
High Yield: Hand hygiene is now the most important measure in infection control. Semmelweis observed that puerperal fever (Group A Streptococcus) rates dropped dramatically when clinicians washed hands with chlorinated lime solution before going from the post-mortem room to the delivery room. [1][3]
What the historical graph shows: The Vienna maternity-ward time series has persistently higher maternal mortality in the doctors'/medical-students' clinic than in the midwives' clinic, followed by an abrupt fall after chlorinated-lime hand cleansing was introduced in 1847. The graph is an early visual demonstration that interrupting transmission can change outcomes even before a pathogen is fully characterised. [1]
Before SARS in 2003, infection control was often neglected — the lecture slide noting healthcare worker deaths (Dr Tse Yuen Man, Dr Cheung Sik Hin, etc.) emphasises that "nobody cares till 2003". The SARS experience transformed infection control from a neglected discipline into a central hospital function. [1]
| Term | Definition | Key Detail |
|---|---|---|
| Community-acquired infection (CAI) | Infection acquired outside healthcare; the lecture/handout uses onset before or within 48 hours of admission as a bedside shorthand | Acquisition and incubation history can override a clock-based rule [3][10] |
| Hospital-acquired infection (HAI) | Infection related to healthcare and not present or incubating when care was delivered | The lecture uses onset after 48 hours; current surveillance uses syndrome-specific definitions and, for many NHSN events, hospital day 3 or later, with important exceptions [1][3][10] |
| Healthcare-associated infection (HCAI) | Infections acquired in healthcare settings other than acute care: nursing homes, dialysis centres, day surgery, chemotherapy units, or identified after discharge | Emerged because modern healthcare extends beyond acute hospital walls [3] |
| Outbreak | A statistically significant increase in occurrence of an infection above the background/baseline rate | May be 1 case of something rare (e.g., SARS) or many cases of something common (e.g., seasonal influenza) [3] |
| Pseudo-outbreak | Clusters of positive cultures without evidence of disease | Causes: lab contamination, change in surveillance methods/definitions [3] |
| Colonisation | Microbe occupies skin/mucosal surface without invasion | May cause disease when host defence weakens [1] |
Exam Trap: CAI vs HAI
A patient admitted with pneumonia that was incubating before admission but only declared 3 days later may still have community-acquired infection if the incubation period and epidemiology support that conclusion. Conversely, some procedure-related HAIs can present after discharge. Use the lecture's 48-hour threshold when reproducing its exam framework, but use the relevant contemporary surveillance case definition in practice. [10]
Historical lecture distribution: The following proportions and the statement that HAI affected about 8% of inpatients are slide-era teaching figures, not current universal prevalence estimates. HAI burden varies by population, setting, case definition and surveillance method. [1][3][10]
| Type | Approximate % | Key Association |
|---|---|---|
| Hospital-acquired UTI | ~30% (most common) | Urinary catheter |
| Hospital-acquired pneumonia | ~20–25% | Ventilator, tracheostomy |
| Surgical site infections | ~15–20% | Operative contamination |
| Intravascular catheter-related BSI | Included in "Others 35%" | Central lines, peripheral cannulae |
| Infected pressure sores | Included in "Others 35%" | Immobility, poor nursing care |
| Blood/blood product infections | Included in "Others 35%" | Transfusion |
HAI organisms may be antimicrobial-resistant: MRSA, ESBL-producing Enterobacterales, carbapenemase-producing Enterobacterales (CPE), carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, and Candida auris. Clostridioides difficile is an important healthcare-associated diarrhoeal pathogen but is not grouped with these organisms simply because it is “MDR.” [3]
2. Modes of Transmission
High Yield — this is the framework the entire lecture (and past papers) revolve around.
Four modes of transmission: (1) Contact, (2) Droplet, (3) Aerosol/Airborne, (4) Parenteral [1]
Direct contact: Person-to-person, skin-to-skin touch. The most common route of nosocomial transmission. Your fingers touch a colonised patient → you touch another patient or yourself → transmission.
Indirect contact: Touching a fomite (contaminated surface/object) and then a susceptible portal of entry. Demonstrating that an organism remains recoverable from a surface does not, by itself, demonstrate efficient clinical transmission from that surface. [1][19]
How to read the surface-survival slide: In the controlled 20 °C experiment shown, recoverable SARS-CoV-2 persisted for up to 28 days on several non-porous materials and paper banknotes, but fell faster on cotton and at higher temperatures. This is a laboratory persistence result under fixed conditions—not proof that ordinary fomites are a major transmission route or that a “durable coating” prevents infection. In practice, use risk-based cleaning of high-touch surfaces with an appropriate product, dilution and labelled contact time. [1][19]
Clinical pathways of contact transmission: [1]
- Finger skin → skin: skin colonisation/infection
- Finger skin → mucosa (eye, nose, mouth): colonisation or acute respiratory infection
- Finger → GI tract (ingestion): GI colonisation or infectious diarrhoea
| Contact-transmitted Pathogens (from lecture) | Category |
|---|---|
| MRSA, VRE, Candida auris | MDR Gram-positive / yeast |
| MDR Enterobacteriaceae & non-fermenters | MDR Gram-negative |
| Norovirus, Rotavirus, C. difficile | Diarrhoeal pathogens |
| HSV, RSV | Viruses |
| Scabies | Parasitic infestation |
| Viral haemorrhagic conjunctivitis | Viral |
| Viral haemorrhagic infections | E.g. Ebola (also droplet/contact) |
| Highly contagious skin infections | Impetigo, etc. |
The lecture presents a traditional droplet-versus-aerosol model: larger particles tend to settle more quickly and may deposit directly on nearby eyes, nose or mouth, whereas smaller particles remain suspended longer and may be inhaled. Distance, ventilation, humidity, respiratory activity and particle size all influence risk. [1][11]
- Sneezing/coughing can produce up to 40,000 droplets of 0.5–12 µm at velocities of 100 m/s [1]
- Speaking also generates large numbers of particles < 5 µm; emission rate correlates with loudness; some individuals are "speech super-emitters" [1]
- The nearer you are to the patient, the higher the density of fine aerosol [1]
| Droplet-transmitted Pathogens (from lecture) |
|---|
| Invasive H. influenzae type b |
| Invasive N. meningitidis |
| Diphtheria (pharyngeal) |
| Adenovirus |
| Influenza virus |
| Parvovirus B19 |
| Mumps & Rubella |
| Mycoplasma pneumoniae |
| Streptococcal pharyngitis |
| Pertussis |
| Pneumonic plague |
Smaller respiratory particles can remain suspended and be inhaled, including beyond close range when ventilation is poor. However, infectious respiratory particles exist on a continuous spectrum: the WHO-led 2024 terminology does not endorse one particle-size cut-off separating “droplet” from “airborne” physics. It describes through-air transmission as inhalation or direct deposition. [11]
Reading the deposition diagram: The slide maps progressively smaller particles to deeper respiratory deposition (nasopharyngeal → tracheobronchial → pulmonary/alveolar). Treat its exact 20/6/5 µm boundaries as a teaching simplification; deposition also depends on aerodynamic diameter, airway anatomy and breathing pattern. [1][11]
High Yield — The "airborne trio" + SARS-CoV-2: [1]
| Pathogen | Key Feature |
|---|---|
| Mycobacterium tuberculosis | Classic airborne; droplet nuclei; prolonged infectivity |
| Varicella zoster virus (VZV / Chickenpox) | Highly contagious; rash + respiratory secretions |
| Measles virus | R0 12–18, most contagious human virus |
| SARS-CoV-2 | Can transmit by inhalation and direct deposition; use the current pathogen-, setting- and procedure-specific guidance rather than a single slide label [11][12] |
The Classic Airborne 3 + 1
For recall of the lecture slide, “MTV-S” = Measles, TB, Varicella, SARS-CoV-2. In clinical practice, keep the operational isolation category distinct from particle physics and follow the current organism-specific table and local policy. [12]
Parenteral routes: arthropod bites, needlestick injuries, surgery, transfusion, tissue/organ transplant. [1]
Bloodborne viruses of greatest concern (directly tested, 2024 SAQ Q12f): [2]
- HBV
- HCV
- HIV
Case illustration — blood product contamination: The lecture shows a case where a remnant blood bag (red cell unit serial 9019776) was found contaminated with Pseudomonas fluorescens at 5×10⁸ CFU/mL, with Gram smear and culture positive. This illustrates that bacterial contamination of blood products (though uncommon with modern screening) can cause fulminant sepsis. [1]
3. Outbreak Investigation — Step-by-Step
The lecture uses the QMH intestinal mucormycosis outbreak (2008–2009) as a teaching case (the slides use the historical term zygomycosis). This is a landmark Hong Kong public health event worth understanding in detail.
- Index patient: 6-year-old boy, good past health, newly diagnosed acute lymphoblastic leukaemia (ALL; blasts 78%), admitted to C6 ward at QMH. After chemotherapy and neutropenia, he developed sudden right-lower-quadrant pain, fever, confusion and hypotension; laparotomy showed necrotic bowel, and Rhizopus microsporus was identified. [1]
Visual recognition from the case slides: The resected bowel is dusky/necrotic. Histology shows broad, irregular, ribbon-like, pauciseptate hyphae—an appearance that should prompt concern for invasive Mucorales in the correct host. The culture becomes rapidly cottony/fluffy, and microscopy shows a sporangium with sporangiospores and rhizoids consistent with Rhizopus. Tissue invasion and vascular thrombosis explain the bowel necrosis; morphology is presumptive and culture or molecular identification establishes the organism. [1]
Step-by-Step Outbreak Investigation
| Step | Action | Application in QMH Outbreak |
|---|---|---|
| Step 1: Verify clinical, microbiological & histological diagnosis | Confirm the infection is real, not a lab artefact | Tissue showed invasive mucormycosis; culture confirmed Rhizopus microsporus group [1] |
| Step 2: Case definition | Develop a working case definition (may be refined as investigation proceeds) | "R. microsporus in stool or intestinal tissue" — then 2-week enhanced surveillance (retrospective + prospective) across all Hospital Authority hospitals [1] |
| Step 3: Line listing | Tabulate cases with demographic, clinical, temporal and exposure data | The QMH line-listing slide contains 12 patients. The preceding HA-wide enhanced-surveillance table totals 20 cases, plus 1 additional case noted separately: 12(+1) colonisation, 1 mucosal and 7 invasive. Do not conflate the two denominators. [1] |
| Step 4: Case finding | Actively search for additional cases via lab records, contact tracing | 394 stool samples screened; 1 additional colonisation case in a non-haem patient [1] |
| Step 5: Epidemic curve | Plot number of cases (Y-axis) vs time (X-axis) | Cases occurred intermittently from Sep 2008 to Mar 2009, with the largest monthly count in Feb 2009; together with the shared exposure, this supports a prolonged/intermittent common source rather than a single sharp point-source peak [1] |
QMH Epidemic Curve — Monthly Case Breakdown: [1]
| Month | Invasive | Mucosal | Colonisation | Total |
|---|---|---|---|---|
| Sep 2008 | 1 | 0 | 0 | 1 |
| Oct 2008 | 0 | 0 | 0 | 0 |
| Nov 2008 | 1 | 0 | 0 | 1 |
| Dec 2008 | 0 | 0 | 0 | 0 |
| Jan 2009 | 2 | 1 | 0 | 3 |
| Feb 2009 | 2 | 0 | 4 | 6 |
| Mar 2009 | 0 | 1 | 1 | 2 |
The largest bar is February 2009 (6 cases). Because cases span several months, the visual pattern is not a “high initial peak”; it is more compatible with continuing or intermittent exposure to a shared source. The later analytical and microbiological evidence identifies that source. [1]
The QMH baseline for intestinal mucormycosis was effectively zero. Even one verified case was unusual; multiple cases clustered in time, in haematology patients and at an unusual anatomical site made an outbreak signal compelling. [1]
Historical baseline data (QMH 1990–2005): Over 15 years, among 5,319 stool samples from the BMT ward, zero were positive for Mucorales. Among 44,940 total BMT-ward specimens, only 1 was positive (a 2004 sputum growing Absidia). Among 145,252 specimens hospital-wide, only 25 positives from 11 patients were found—none from stool or intestinal tissue. This confirms that intestinal mucormycosis was unprecedented at QMH. [1]
Outbreak versus sporadic mucormycosis: [1]
| Feature | Outbreak (QMH 2008–09) | Sporadic |
|---|---|---|
| Temporal pattern | Clustering | No clustering |
| Site | Intestinal (unusual) | Pulmonary, rhinocerebral, cutaneous |
| Risk factors | No unusual risk factors beyond chemotherapy | Presence of classic risk factors (DM, iron overload, deferoxamine) |
| Step | Action | Application in QMH Outbreak |
|---|---|---|
| Step 7: Case-control study | Identify risk factors by comparing cases to matched controls | 9 cases vs 45 controls. Two factors reached statistical significance (p < 0.001): intake of allopurinol and intake of specific ready-to-eat food [1] |
| Step 8: Environmental/microbiological surveillance | Culture environmental samples, food, drugs, instruments | Of 709 specimens, positives came from food (5/181), drugs (1/150) and utensils (1/19); environmental samples (0/311), instruments (0/48) were negative [1] |
| Step 9: Molecular typing | Establish clonality between patient and environmental isolates | ITS1-5.8S-ITS2 rRNA gene cluster sequencing identified 2 sequence types linking patient isolates to drug and food isolates [1] |
High Yield — what the culture photographs add: Roll-plating the tablets produced colonies directly around the tablets. All four batches were positive internally, with fungal count > 1,000/g, while surface swabs were negative—evidence for contamination within the product rather than simple external handling contamination. The allopurinol contained corn starch, a plausible substrate and contamination vehicle for Mucorales. [1]
What the phylogenetic tree adds: Two ITS sequence types were present. Sequence type 1 linked four patient isolates with five drug, two food and one corn-starch isolate; sequence type 2 linked two patient isolates with one drug and two food isolates. This is stronger than merely finding the same species: it connects patient and product/ingredient isolates at the molecular-typing level, while also showing that the event was not represented by only one sequence type. [1]
Attack rate on the slide = (mucosal + invasive)/total = 6/18 = 33.3%. Only 1 of 8 symptomatic patients survived (12.5% survival). The later bar chart is a historical projection, not an observed one-year outcome: extrapolating the detected rate gives 54 total, 36 asymptomatic and 18 symptomatic cases, from which the slide estimates about 16 lives saved by intervention. [1]
Why Allopurinol?
Haematology patients on chemotherapy routinely receive allopurinol for tumour lysis syndrome prophylaxis (urate-lowering). The allopurinol tablets from a Chinese/HK manufacturer (Europharm) contained corn starch as an inactive ingredient. Corn starch is an excellent substrate for Mucorales (bread moulds). The corn starch used was manufactured by Tongaat Hulett Starch (South Africa). The manufacturing process failed to eliminate fungal contamination. The European Pharmacopoeia sets microbial limits for oral/rectal preparations: bacteria < 10³/g, fungi < 10²/g, and E. coli absent in 1 g. The contaminated allopurinol had > 1000 fungi/g — a 10-fold breach of the fungal limit. [1]
A high initial peak suggests a single, shared "common source" (e.g. contaminated food/drug batch). Controlling the source stops the outbreak. Person-to-person outbreaks give a longer, flatter curve with propagating peaks. [3]
Multidrug-resistant bacteria are often acquired silently from patients or food; and kill you many months or years later. [1]
The lecture diagram illustrates the cycle:
- Selective antibiotic pressure in hospitalised patients → resistant organisms (R) survive while susceptible organisms (S) are killed
- Resistant organisms colonise the patient
- Healthcare workers' hands pick up R organisms
- R organisms transfer to other patients, instruments, environment, clothing, shed skin scales
- Colonised/infected patients become new reservoirs
The adjacent network diagram makes the amplification problem visible: one colonised carrier can seed multiple patients through contaminated hands and the care environment, and those secondary carriers become new nodes. Break the cycle with hand hygiene, appropriate precautions, environmental/equipment cleaning and antimicrobial stewardship—not with antibiotics alone. [1]
5. Infection Control System: Two-Tier Precautions
High Yield: Standard precautions are applicable to ALL patients, regardless of diagnosis. They reduce the risk of transmission even when the presence of an infectious agent is unsuspected. [1][3]
Apply whenever contact with blood, body fluids, non-intact skin, mucous membranes, and secretions (except sweat) is possible. [1]
| Component | Details |
|---|---|
| Gloves | When handling blood, all body fluids, secretions, excretions, mucous membranes, or non-intact skin |
| Hand hygiene | Before and after patient contact as indicated; after body-fluid exposure risk; after touching patient surroundings; immediately after glove removal; when moving from a contaminated to a clean body site |
| Masks + eye protection | For splash-prone procedures |
| Gowns | Disposable 100% polypropylene for splash-prone procedures |
| Needle safety | NEVER recap needles; dispose in puncture-resistant sharps container |
| Waste | Soiled linen/contaminated materials in impervious bags |
High Yield: "Hand hygiene: single most important infection control measure against nosocomial transmission of microbes." [1]
| Method | Agent | Duration | When to Use |
|---|---|---|---|
| Alcohol-based handrub | Product containing at least 60% alcohol; use enough to cover all hand surfaces | Rub until dry, typically about 20 seconds | Preferred in most clinical situations when hands are not visibly soiled [13] |
| Handwashing | Plain or antimicrobial soap + water according to local policy | Lather/scrub all surfaces for at least 15 seconds (20 seconds is also accepted), then rinse and dry | When hands are visibly soiled; before eating; after using the toilet; and during care in outbreaks of C. difficile or norovirus [13] |
WHO “Five Moments” shown in the handout: before touching a patient; before a clean/aseptic procedure; after body-fluid exposure risk; after touching a patient; and after touching patient surroundings. [3]
Alcohol vs Soap
Alcohol-based handrub is the default in most clinical situations because it is rapid and practical at the point of care. It does not reliably eliminate C. difficile spores, but current CDC guidance still prioritises glove use and hand hygiene and does not require routine soap-and-water use after every C. difficile encounter; facilities may preferentially encourage soap and water during outbreaks. Always use soap and water when hands are visibly soiled. [13]
Applied when a specific diagnosis is suspected or documented, IN ADDITION to standard precautions. [1]
| Precaution Type | Rationale | Key Agents | Methods |
|---|---|---|---|
| Airborne | Operational category for agents that remain infectious over distance/time under relevant conditions | TB, VZV, measles; apply current local respiratory-pathogen guidance for SARS-CoV-2 | Airborne infection-isolation room where indicated; closed door; fit-tested particulate respirator (e.g. N95 or higher) [12] |
| Droplet | Operational category addressing close-range respiratory exposure/direct deposition | Influenza, invasive meningococcal disease, pertussis and others listed in current pathogen-specific guidance | Medical/surgical mask on entry and appropriate eye protection when exposure risk indicates; source control and patient placement per policy [12] |
| Contact | Direct/indirect transfer from patient or contaminated environment/equipment | MRSA, VRE, C. auris, MDR GNB, diarrhoeal pathogens, HSV, RSV, scabies | Gown and gloves as specified for the organism/interaction; dedicated or disinfected equipment; hand hygiene [12] |
The slide's “droplet > 5 µm / airborne < 5 µm” table is a historical simplification, and its “gloves for all patient contact” wording is broader than risk-based standard precautions. Precaution labels remain useful operational bundles, but do not imply a hard physical size boundary. [1][11][12]
High Yield — Mask Layers: The surgical mask has 3 layers: (1) water-repellent outer layer, (2) microbe-filtering melt-blown polypropylene middle layer, (3) water-absorbent inner layer. Always perform hand hygiene before putting on a respirator and perform a fit check every time for N95. [1]
N95 fit testing and seal check: Fit testing is required before use and periodically under the applicable occupational-health programme (at least annually under US OSHA rules), and again when the respirator model/size changes or facial changes may affect fit. The handout uses ±10% weight change as a local trigger. A user seal check is still required every time the respirator is donned; it does not replace formal fit testing. [3][12]
Proper N95 Application Steps: [1]
- Select regular or small-size mask according to face shape; loosen neck strap; ensure metal flexible strip faces upward
- Place straps separately over the top of the head and behind the neck
- Using index and middle fingers of both hands, press the metal strip simultaneously from centre toward both sides
- Perform a fit check every time
6. Sharps Injuries & Bloodborne Pathogens
Historical context only: The slide's US healthcare-worker mortality estimates are from 2000–2002 and should not be presented as current risk. They estimate 80–260 infection-related versus 77–93 injury-related deaths among 6.2 million healthcare workers, with HBV accounting for most of the estimated infection-related deaths. [1]
High Yield: [1]
| Step | Action |
|---|---|
| Prevention | HBV vaccination and documented response where indicated; safety devices; do not recap used needles; immediate sharps disposal [14][15] |
| First aid | Wash needlestick/cut with soap and water; flush splashes to nose, mouth or skin with water; irrigate eyes. Do not add wound squeezing as a recommended step. Report immediately and obtain urgent occupational-health/emergency assessment [14] |
| Risk assessment/testing | Assess exposure route/severity and source status; obtain consent and test source/worker according to local protocol without delaying indicated HIV PEP [14][17] |
| HIV | Start PEP as soon as possible after a substantial-risk exposure; do not wait for all results. Contemporary occupational regimens are given for 28 days, with expert/local-protocol follow-up [17] |
| HBV | Management depends on source HBsAg, worker vaccination history and documented anti-HBs response; vaccine and/or HBIG are used only when indicated—not automatically for every exposure [15] |
| HCV | No recommended PEP. Baseline testing, HCV RNA at 3–6 weeks when indicated, and final anti-HCV testing at 4–6 months; link early infection to care [16] |
No PEP for HCV
There is no recommended post-exposure prophylaxis for HCV. Follow the exposed worker with the recommended HCV RNA/antibody schedule and link confirmed infection promptly to treatment. [16]
7. Scope of Infection Control (from Lecture Slide)
The scope of infection control includes: [1]
- Surveillance — ongoing data collection to establish baseline rates
- Outbreak investigations — when rates exceed baseline
- Hand hygiene, standard precautions, isolation procedures
- Setting and implementation of guidelines for patient care procedures, disinfection/sterilisation
- Monitor staff health and immunisation status
- Antimicrobial optimisation (stewardship) programme
- Led by an Infection Control Officer (clinical microbiologist or trained physician) [3]
- Infection Control Nurse (ratio: 1 per 250 beds in HK) [3]
- Roles include: annual IC plan, surprise ward visits, surveillance, outbreak investigation, education, needle-stick monitoring, antibiotic stewardship collaboration, environmental cleaning oversight [3]
The final outcome is determined by the interaction between the microbe and host defence/underlying disease. Infection control procedures: [1]
- Reduce risk and delay onset of HAI
- Prevent outbreaks or cross-infection (protect patients, staff, visitors)
- Cost saving
From the 2021 MCQ Q97 (COVID-19 universal community testing programme): the answer is Active surveillance. [4]
| Type | Definition | Example |
|---|---|---|
| Active surveillance | Health authority actively seeks out cases (e.g. universal testing, contact tracing) | COVID-19 universal community testing |
| Passive surveillance | Cases reported to authorities by clinicians/labs (standard notifiable disease reporting) | Statutory notification of TB |
| Sentinel surveillance | Selected sites/providers report on a specific condition | ILI surveillance at selected clinics |
| Syndromic surveillance | Monitors symptom patterns (not lab-confirmed diagnoses) | ED chief complaint data for early outbreak detection |
9. Additional Clinical Vignettes from the Lecture
- F/23, D20 post-C-section, persistent wound pain and discharge
- P/E: 37.5°C, inflamed wound, serous discharge, indurated wound edge
- Pus C/ST: WBC +++, No growth → reconsider specimen processing and organisms not recovered by a routine short-incubation bacterial workflow
- Within 2 weeks, 35 similar cases at the same hospital
- The tissue image shows dense neutrophilic inflammation; the special stain shows sparse, slender, beaded acid-fast bacilli, pointing toward a rapidly growing nontuberculous mycobacterium rather than ordinary pyogenic bacteria [1]
- The published Shenzhen Women and Children's Hospital outbreak organism was Mycobacterium chelonae, not M. abscessus. “Rapidly growing” mycobacteria can produce visible growth within about 7 days under suitable culture conditions; routine workflows may be discarded too early or lack the appropriate work-up [18][20]
- Speciation requires mycobacterial culture and/or molecular methods. Do not infer “instruments or water” from this image alone; outbreak investigation must link the organism to a source/process. [18]
- F/37, assistant nurse in a CU clinic, presented with malaise, fever × 1 month, weight loss, and night sweats [1]
- CXR: Left-sided massive pleural effusion with collapse
- Sputum AFB: Positive → diagnosed with open pulmonary TB
- Known HBsAg carrier; baseline LFTs normal; albumin 20 g/L; started full-dose anti-TB treatment (body weight 45 kg)
- Over subsequent years, serial tables show resistance accumulating to isoniazid, rifampin, ethambutol, pyrazinamide, streptomycin, kanamycin, ofloxacin, ethionamide, amikacin and capreomycin; the final slide reports susceptibility only to cycloserine [1]
- Outcome: Admitted aged 45 with end-stage respiratory failure and destroyed left lung; no effective chemotherapy available; died 3 days after admission [1]
- Teaching point: The radiographs visually progress from major left pleural/lung disease to a destroyed left lung. This historical case illustrates cumulative resistance and the need for rapid diagnosis, effective multidrug therapy, adherence support, airborne precautions and stewardship. The slide's phrase “extremely multidrug-resistant” is descriptive historical wording; do not map it automatically to the current WHO formal XDR-TB definition.
| Topic | Connection |
|---|---|
| GC 099 Antimicrobial Resistance | MDR organisms (MRSA, ESBL, CPE) are the main HAI pathogens; antimicrobial stewardship is part of IC scope |
| GC 061 HIV/Needlestick | Urgent exposure assessment; HIV PEP for 28 days when indicated; HBV prophylaxis depends on source and worker immunity; no HCV PEP |
| GC 102 Fever after Chemotherapy | Neutropenic fever patients are the most vulnerable to HAI; reverse isolation, hand hygiene, low-bacteria diet |
| GC 103 Fever after Travelling | Returning travellers with pneumonia: consider airborne isolation for TB, MERS, novel influenza [6] |
| CFB WCS27 Surgical Infection | Infection control teams, patient isolation, ward discipline, antibiotic stewardship [7] |
| GC 107 Protect Yourself and Your Patients | Reinforces PPE, hand hygiene, vaccination |
| Trap | Correct Approach |
|---|---|
| Treating 5 µm as a hard physics boundary | The slide's split is historical. Infectious respiratory particles form a continuum; precaution categories are operational bundles [11][12] |
| Assuming a surgical mask and a respirator are interchangeable | A medical mask is not a fit-tested particulate respirator; use the PPE specified by the current pathogen/procedure risk assessment [12] |
| Assuming alcohol handrub kills C. difficile spores | It is not reliably sporicidal. Use gloves and hand hygiene; wash with soap and water when visibly soiled and when outbreak/local guidance directs [13] |
| Memorising SARS-CoV-2 as a timeless single-category label | The slide places it in the airborne list; current practice uses setting-, procedure- and pathogen-specific respiratory protection guidance [11][12] |
| Confusing outbreak with pseudo-outbreak | Pseudo-outbreak = positive cultures but no clinical disease (lab contamination, changed surveillance) |
| Thinking HCV has PEP | No recommended PEP for HCV; use baseline/follow-up testing and link infection to care [16] |
| Treating 48 hours as a universal HAI definition | It is the lecture shorthand; current surveillance definitions are syndrome-specific and include exceptions [10] |
High Yield Summary
- HAI: healthcare-related and not present/incubating when care was delivered. “After 48 hours” and the 8%/site proportions are lecture-era shorthand, not universal current definitions or prevalence.
- Transmission framework: contact, respiratory (operational droplet/airborne precautions) and parenteral. Respiratory particles form a continuum rather than obeying a hard 5 µm boundary.
- Two-tier system: standard precautions for every patient, plus diagnosis/risk-specific contact, droplet or airborne precautions.
- Hand hygiene: use alcohol-based handrub in most clinical situations; soap and water when visibly soiled and for other specified indications.
- Outbreak workflow: verify diagnosis → define/line-list/find cases → epidemic curve/baseline comparison → analytical epidemiology → environmental microbiology → molecular typing → control and follow-up surveillance.
- QMH source evidence: internally contaminated allopurinol tablets, positive across four batches, with patient/product/food/corn-starch isolates linked by two ITS sequence types.
- Sharps exposure: immediate wash/irrigation and urgent reporting; start indicated HIV PEP promptly for 28 days; tailor HBV prophylaxis to immunity/source; no HCV PEP.
- PPE: a surgical mask is not a fit-tested respirator; use organism-, task- and local-policy-specific protection.
Active Recall - Infection Outbreak & Infection Control
[1] Lecture slides: GC 104. Infection outbreak_infection control.pdf [2] Past papers: 2024 Fourth Summative SAQ.pdf (Question 12) [3] Lecture slides: GC 104. Infection outbreak_infection control [Handout].pdf [4] Past papers: 2021 Fourth Summative Assessment MCQ.pdf (Question 97) [5] Senior notes: Block A - Fever after a blood transfusion_ transfusion and related problems.pdf [6] Past papers: 2018 Fourth Summative Minicase.pdf (Section 4, Q11) [7] Lecture slides: CFB WCS27_Surgical Infection.pdf [10] US CDC. About Healthcare-Associated Infections; NHSN FAQs and Patient Safety Component definitions (current pages accessed 2026). [11] World Health Organization. Global technical consultation report on proposed terminology for pathogens that transmit through the air (2024). [12] US CDC. Standard Precautions; Transmission-Based Precautions; Appendix A pathogen-specific precautions; Viral Respiratory Pathogens Core Prevention Strategies. OSHA. Respiratory Protection, 29 CFR 1910.134. [13] US CDC. Clinical Safety: Hand Hygiene for Healthcare Workers (current page accessed 2026). [14] US CDC/NIOSH. Bloodborne Infectious Disease Risk Factors (occupational exposure first aid and prevention; current page accessed 2026). [15] US CDC. Responding to HBV Exposures in Health Care Settings (current page accessed 2026). [16] US CDC. Guidelines for Health Care Personnel Exposed to Hepatitis C Virus (current page accessed 2026). [17] US Public Health Service. Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis (2025). [18] Weng K-R et al. Treatment and a follow-up study on wound infection by Mycobacterium chelonae: report of 168 cases. Zhonghua Jie He He Hu Xi Za Zhi. 2004;27(5):328–331. [19] US CDC. Environmental Infection Control / Environmental Services (current pages accessed 2026). [20] US CDC. Chemical Disinfectants (rapidly growing mycobacteria; current page accessed 2026).
GC103 Fever After Travelling
Fever occurring in a patient who has recently traveled, particularly to tropical or endemic regions, requiring systematic evaluation for infections such as malaria, dengue, typhoid, and other travel-related diseases.
GC105 Medically Important Microbes What Every Doctor Should Know
A foundational medical microbiology framework covering the essential bacteria, viruses, fungi, and parasites that clinicians must recognize for accurate diagnosis, appropriate antimicrobial therapy, and effective infection control.